Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rhun E Le"'
Autor:
Roth, P., Pace, A., Rhun, E. le, Weller, M., Ay, C., Moyal, E.C.J., Coomans, M., Giusti, R., Jordan, K., Nishikawa, R., Winkler, F., Hong, J.T., Ruda, R., Villa, S., Taphoorn, M.J.B., Wick, W., Preusser, M., EANO Executive Board, ESMO Guidelines Comm
Publikováno v:
Annals of Oncology, 32(2), 171-182. ELSEVIER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48f641f670a7215729fd49a4769e47b
https://hdl.handle.net/1887/3251137
https://hdl.handle.net/1887/3251137
Autor:
Jordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H.S., Jahn, P., Rhun, E. le, Preusser, M., Scotte, F., Taphoorn, M.J.B., Jordan, K., ESMO Guidelines Comm, EONS Educ Working Grp, EANO Guideline Comm
Publikováno v:
Annals of Oncology, 31(10), 1306-1319. ELSEVIER
Annals of Oncology
Annals of Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba437ab355942254cea9f3a80bce1100
https://hdl.handle.net/1887/3182767
https://hdl.handle.net/1887/3182767
Autor:
Dirven, L., Armstrong, T.S., Blakeley, J.O., Brown, P.D., Grant, R., Jalali, R., Leeper, H., Mendoza, T., Nayak, L., Reijneveld, J.C., Rhun, E. le, Walbert, T., Weller, M., Wen, P.Y., Taphoorn, M.J.B.
Publikováno v:
The Lancet Oncology, 19(3), E173-E180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eb06685eb002903a6b99e803a57182d2
https://hdl.handle.net/1887/96514
https://hdl.handle.net/1887/96514
Autor:
Weller, M., Bent, M. van den, Tonn, J.C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., Henriksson, R., Rhun, E. le, Balana, C., Chinot, O., Bendszus, M., Reijneveld, J.C., Dhermain, F., French, P., Marosi, C., Watts, C., Oberg, I., Pilkington, G., Baumert, B.G., Taphoorn, M.J.B., Hegi, M., Westphal, M., Reifenberger, G., Soffietti, R., Wick, W., European Assoc Neuro-Oncology EANO
Publikováno v:
The Lancet Oncology, 18(8), E430-E431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e08afebe27e1614dfc8972deac584575
https://hdl.handle.net/1887/115068
https://hdl.handle.net/1887/115068
Autor:
Pace, A., Dirven, L., Koekkoek, J.A.F., Golla, H., Fleming, J., Ruda, R., Marosi, C., Rhun, E. le, Grant, R., Oliver, K., Oberg, I., Bulbeck, H.J., Rooney, A.G., Henriksson, R., Pasman, H.R.W., Oberndorfer, S., Weller, M., Taphoorn, M.J.B., European Assoc Neuro-Oncology
Publikováno v:
The Lancet Oncology, 18(6), E330-E340
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::70c976741d67b25ec58b951cff09c72b
https://www.zora.uzh.ch/id/eprint/141055/
https://www.zora.uzh.ch/id/eprint/141055/
Autor:
Rhun E Le, Younès I Ben, M. Campone, Gilles Romieu, Aït-Oukhatar C Mahier, C. Labbe-Devilliers, Thomas Bachelot, A. Gonçalves, J-P Borg, Luc Camoin, Véronique Diéras, Florence Dalenc, Claire Cropet
Publikováno v:
Cancer Research. 72:P3-12
Background: The LANDsCAPE phase II study showed that C+L had a significant antitumor activity in previously untreated brain metastases (BM) from HER2-positive breast cancer (BC), with a central nervous system-objective response rate (CNS-ORR) of 67%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53acf5e6f508bec88c2afcf076b04bea
https://doi.org/10.1158/0008-5472.sabcs12-p3-12-01
https://doi.org/10.1158/0008-5472.sabcs12-p3-12-01
Autor:
L Vanlemmens, X Delbeuck, V Servent, A Mailliez, C Lefeuvre-Plesse, P Kerbrat, T Petit, C Fournier, Y Vendel, S Clisant, J Bonneterre, F Pasquier, Rhun E Le
Publikováno v:
Cancer Research. 72:P2-13
Background: Cognitive impairment has been considered to be a possible adverse effect of aromatase inhibitors (AI). The aim of the study was to compare the impact of tamoxifen or AI on verbal memory (Rey auditory-verbal learning test) and other cognit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812d06f1855e7e352bdb1fd0e9ef88fd
https://doi.org/10.1158/0008-5472.sabcs12-p2-13-10
https://doi.org/10.1158/0008-5472.sabcs12-p2-13-10
Autor:
F. Mercier, C. Maillard, Rhun E Le, C. Moldovan, Christelle Levy, Sandrine Baffert, Séverine Guiu, L Benjamin, S. Laulhère-Vigneau, François-Emery Cotté, PH Cottu, Y.M. Kirova, N Madrange, Daniel Serin, C. Simondi, Thomas Bachelot, Isabelle Durand-Zaleski, Maya Gutierrez
Publikováno v:
Cancer Research. 71:P1-10
Background HER2+ status is associated with poor prognosis and a high incidence of brain metastases (BM) in breast cancer (BC). Addition of HER2−targeted therapies to conventional chemotherapy has significantly improved survival in HER2+ patients (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c43481f99a226096983cf7025fe8460b
https://doi.org/10.1158/0008-5472.sabcs11-p1-10-02
https://doi.org/10.1158/0008-5472.sabcs11-p1-10-02
Autor:
Preusser, M, Silvani, A, Rhun, E Le, Soffietti, R, Lombardi, G, Sepulveda, J, Brandal, P, Beaney, R, Bonneville-Levard, A, Lorgis, V, Bromberg, J, Erridge, S, Cameron, A, Marosi, C, Golfinopoulos, V, Gorlia, T, Weller, M, Wick, W
Publikováno v:
Neuro-Oncology; 2019 Supplement, Vol. 21, piii2-iii3, 2p
Autor:
Wolpert, F, Grossenbacher, B, Lareida, A, Roth, P, Neidert, M C, Andratschke, N, Rhun, E Le, Weller, M
Publikováno v:
Neuro-Oncology; 2019 Supplement, Vol. 21, piii72-iii72, 1p